TMO Q4 2016 Earnings Report — Thermo Fisher Scientific Inc. Revenue & Financial Results | Market Cap Arena

Thermo Fisher Scientific Inc.TMO

Q4 2016 Earnings

Reported February 28, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q4 2016	Q3 2016	Q4 2015	QoQ Change	YoY Change
Revenue	$5.0B	$4.5B	—	10.3%	—
Op. Income	$847M	$695M	—	22.0%	—
Gross Margin	47.3%	47.1%	—	0.3pp	—
Net Margin	12.7%	10.5%	—	2.2pp	—
EPS (Diluted)	$1.59	$1.19	—	33.6%	—
Free Cash Flow	$1.1B	$691M	—	55.2%	—

Revenue Flow

Item	Amount
REVENUE	$5.0B
Cost of Revenue	$2.6B
GROSS PROFIT	$2.3B
R&D Expenses	$213M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.3B
Other Expenses	$28M
Operating Expenses	$1.5B
Cost & Expenses	$4.1B
OPERATING INCOME	$847M
Interest Income	$14M
Interest Expense	$131M
Other Income/Expenses	-$195M
INCOME BEFORE TAX	$652M
Income Tax Expense	$19M
Net Income from Continuing Ops	$633M
Net Income from Discontinued Ops	-$3M
Other Adjustments	$0
NET INCOME	$630M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$630M
D&A	$474M
EBIT	$783M
EBITDA	$1.3B
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$5.0B
Cost of Revenue	$2.6B
GROSS PROFIT	$2.3B
R&D Expenses	$213M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.3B
Other Expenses	$28M
Operating Expenses	$1.5B
Cost & Expenses	$4.1B
OPERATING INCOME	$847M
Interest Income	$14M
Interest Expense	$131M
Other Income/Expenses	-$195M
INCOME BEFORE TAX	$652M
Income Tax Expense	$19M
Net Income from Continuing Ops	$633M
Net Income from Discontinued Ops	-$3M
Other Adjustments	$0
NET INCOME	$630M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$630M
D&A	$474M
EBIT	$783M
EBITDA	$1.3B
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$633M
Depreciation & Amortization	$474M
Stock-Based Compensation	$32M
Deferred Income Tax	-$83M
Other Non-Cash Items	$57M
Change in Working Capital	$95M
OPERATING CASH FLOW	$1.2B
Capital Expenditure	-$134M
Acquisitions (Net)	-$35M
Purchases of Investments	-$78M
Sales/Maturities of Investments	$81M
Other Investing Activities	$78M
NET CASH FROM INVESTING	-$88M
Net Debt Issuance	-$1.9B
Common Stock Repurchased	-$250M
Common Dividends Paid	-$59M
Other Financing Activities	$11M
NET CASH FROM FINANCING	-$2.2B
FREE CASH FLOW	$1.1B
Net Change in Cash	-$1.2B

Balance Sheet

Item	Amount
Cash & Equivalents	$786M
Short-Term Investments	$0
Net Receivables	$3.0B
Inventory	$2.2B
Other Current Assets	$973M
TOTAL CURRENT ASSETS	$7.0B
PP&E (Net)	$2.6B
Goodwill	$21.3B
Intangible Assets	$14.0B
Long-Term Investments	$37M
Tax Assets	$0
Other Non-Current Assets	$975M
TOTAL NON-CURRENT ASSETS	$38.9B
TOTAL ASSETS	$45.9B
Account Payables	$926M
Short-Term Debt	$1.3B
Deferred Revenue	$486M
Other Current Liabilities	$1.3B
TOTAL CURRENT LIABILITIES	$4.9B
Long-Term Debt	$15.4B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.6B
Other Non-Current Liabilities	$1.6B
TOTAL NON-CURRENT LIABILITIES	$19.5B
TOTAL LIABILITIES	$24.4B
Common Stock	$415M
Additional Paid-In Capital	$12.1B
Retained Earnings	$13.9B
Treasury Stock	-$2.3B
Accum. Other Comp. Income	-$2.6B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$21.5B
Minority Interest	$0
TOTAL EQUITY	$21.5B
TOTAL LIABILITIES & EQUITY	$45.9B
Total Debt	$16.6B
Net Debt	$15.8B